These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37120118)

  • 1. Review of the Mechanism of Action and Use of Bisphosphonates in Horses.
    Yocom A; Contino E; Kawcak C
    J Equine Vet Sci; 2023 Aug; 127():104503. PubMed ID: 37120118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonates: from the laboratory to the clinic and back again.
    Russell RG; Rogers MJ
    Bone; 1999 Jul; 25(1):97-106. PubMed ID: 10423031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What Do We Know About Clodronate Now? A Medical and Veterinary Perspective.
    Markell R; Saviola G; Barker EA; Conway JD; Dujardin C
    J Equine Vet Sci; 2020 May; 88():102874. PubMed ID: 32303308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates for breast cancer.
    Pavlakis N; Schmidt R; Stockler M
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and residence time of bisphosphonates in bone of horses.
    Knych HK; Janes J; Kennedy L; McKemie DS; Arthur RM; Samol MA; Uzal FA; Scollay M
    J Vet Diagn Invest; 2022 Jan; 34(1):23-27. PubMed ID: 34918585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of bisphosphonates in breast and prostate cancers.
    Brown JE; Neville-Webbe H; Coleman RE
    Endocr Relat Cancer; 2004 Jun; 11(2):207-24. PubMed ID: 15163299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates: the first 40 years.
    Russell RG
    Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonates for breast cancer.
    Pavlakis N; Stockler M
    Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clodronate detection and effects on markers of bone resorption are prolonged following a single administration to horses.
    Knych HK; Finno CJ; Katzman S; Ryan D; McKemie DS; Kass PH; Arthur RM
    Equine Vet J; 2023 Jul; 55(4):696-706. PubMed ID: 35871470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of geranylgeranylation in bone resorption and its suppression by bisphosphonates in fetal bone explants in vitro: A clue to the mechanism of action of nitrogen-containing bisphosphonates.
    van beek E; Löwik C; van der Pluijm G; Papapoulos S
    J Bone Miner Res; 1999 May; 14(5):722-9. PubMed ID: 10320520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibitory effects of bisphosphonates on bone resorption].
    Shinoda H
    Nihon Yakurigaku Zasshi; 1995 May; 105(5):285-94. PubMed ID: 7628780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonates: The role of chemistry in understanding their biological actions and structure-activity relationships, and new directions for their therapeutic use.
    Ebetino FH; Sun S; Cherian P; Roshandel S; Neighbors JD; Hu E; Dunford JE; Sedghizadeh PP; McKenna CE; Srinivasan V; Boeckman RK; Russell RGG
    Bone; 2022 Mar; 156():116289. PubMed ID: 34896359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonistic effects of different classes of bisphosphonates in osteoclasts and macrophages in vitro.
    Frith JC; Rogers MJ
    J Bone Miner Res; 2003 Feb; 18(2):204-12. PubMed ID: 12568397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the molecular mechanisms of action of bisphosphonates.
    Rogers MJ
    Curr Pharm Des; 2003; 9(32):2643-58. PubMed ID: 14529538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of bisphosphonate.].
    Nakamura M; Koide M; Udagawa N
    Clin Calcium; 2016; 26(11):1561-1570. PubMed ID: 27777389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates--history and experimental basis.
    Fleisch H
    Bone; 1987; 8 Suppl 1():S23-8. PubMed ID: 3318890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease.
    Fleisch H
    Drugs; 1991 Dec; 42(6):919-44. PubMed ID: 1724640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.
    Nancollas GH; Tang R; Phipps RJ; Henneman Z; Gulde S; Wu W; Mangood A; Russell RG; Ebetino FH
    Bone; 2006 May; 38(5):617-27. PubMed ID: 16046206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates and other bone agents for breast cancer.
    O'Carrigan B; Wong MH; Willson ML; Stockler MR; Pavlakis N; Goodwin A
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD003474. PubMed ID: 29082518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonates: biological response modifiers in breast cancer.
    Paterson AH
    Clin Breast Cancer; 2002 Aug; 3(3):206-16; discussion 217-8. PubMed ID: 12196279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.